Header image

Session 3: Acute Leukemia

Tracks
Plenary Hall
Thursday, October 8, 2026
2:50 PM - 4:40 PM

Speaker

Agenda Item Image
Prof. Farhad Ravandi-Kashani
Professor of Medicine and Chief of Section of Acute Myeloid Leukemia in the Department of Leukemia
The University of Texas MD Anderson Cancer Center

Genomic Risk Stratification in AML: From ELN 2022 to Practice

1:40 PM - 2:05 PM

Biography

Agenda Item Image
Dr. Naval Daver
Associate Professor, Department of Leukemia
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

CAR-T Cell Therapy in Acute Leukemia: Access, Selection, and Outcomes

2:05 PM - 2:30 PM

Biography

Dr. Naval Daver is an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center. He completed his medical school from Grant Medical College and Sir J group of Hospitals Mumbai, followed by a residency and fellowship in hematology-oncology from Baylor College of Medicine. He is a clinical investigator with a focus on molecular and immune therapies in AML and Myelofibrosis and is principal investigator on >25 ongoing institutional, national and international clinical trials clinical trials: Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure disease, you may want to consider taking part in a clinical trial, also called a research study. Understanding Clinical Trials Clinical…in these diseases.
Agenda Item Image
Prof. Farhad Ravandi-Kashani
Professor of Medicine and Chief of Section of Acute Myeloid Leukemia in the Department of Leukemia
The University of Texas MD Anderson Cancer Center

Chemo-Free and Low-Intensity Regimens in Adult ALL

2:30 PM - 2:55 PM

Biography

Agenda Item Image
Dr. Naval Daver
Associate Professor, Department of Leukemia
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Targeted Therapies in AML: FLT3, IDH1/2, and Menin Inhibitors

2:55 PM - 3:20 PM

Biography

Dr. Naval Daver is an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center. He completed his medical school from Grant Medical College and Sir J group of Hospitals Mumbai, followed by a residency and fellowship in hematology-oncology from Baylor College of Medicine. He is a clinical investigator with a focus on molecular and immune therapies in AML and Myelofibrosis and is principal investigator on >25 ongoing institutional, national and international clinical trials clinical trials: Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure disease, you may want to consider taking part in a clinical trial, also called a research study. Understanding Clinical Trials Clinical…in these diseases.

Session Chair

Agenda Item Image
Mahdiya Al Bulushi
Consultant Hematologist
The Royal Hospital

Agenda Item Image
Murtadha Al Khabori
Senior Consultant, University Medical City
Professor of Hematology, Sultan Qaboos University

Agenda Item Image
Mohammed Alhuneini
Senior Consultant Hematologist
University Medical City (NOCBMTH)

loading